|
Cetuximab
|
CEB-Y28
|
Mouse |
Anti-Cetuximab Antibodies
|
Hybridoma |
|
|
|
|
|
Adalimumab
|
ADB-Y19
|
Mouse |
Anti-Adalimumab Antibodies
|
Hybridoma |
|
|
|
|
|
CD3 epsilon
|
CDE-M525a
Avitag
|
Mouse |
Biotinylated Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a,Avitag™ (Clone: OKT3), Ultra-low endotoxin
|
HEK293 |
|
|
|
|
|
DNP
|
DNP-FM2
|
Human |
FITC-Labeled Monoclonal Anti-DNP antibody, Human IgG1 Isotype Control
|
HEK293 |
|
|
|
|
|
DNP
|
DNP-FM1
|
Mouse |
FITC-Labeled Monoclonal Anti-DNP antibody, Mouse IgG1 Isotype Control (carrier free)
|
HEK293 |
|
|
|
|
|
BCMA
|
BCA-M43
|
Mouse |
Anti-BCMA Neutralizing Antibody, Mouse IgG1 (recommended for neutralizing assay)
|
HEK293 |
|
|
|
|
|
Dinitrophenyl (DNP)
|
DNP-M2
|
|
Monoclonal Anti-DNP antibody, Human IgG1 Isotype Control (MALS verified)
|
HEK293 |
|
|
|
|
|
Dinitrophenyl (DNP)
|
DNP-MB273
|
|
Monoclonal Anti-DNP antibody, Human IgG1 (N297A) Isotype Control (MALS verified)
|
HEK293 |
|
|
|
|
|
Rituximab
|
RIB-FY35c
|
Mouse |
FITC-Labeled Anti-Rituximab Antibodies, Mouse IgG1
|
Hybridoma |
|
|
|
|
|
Rituximab
|
RIB-Y35c
|
Mouse |
Anti-Rituximab Antibodies (MALS verified)
|
HEK293 |
|
|
|
|
|
Rituximab
|
RIB-Y37
|
Mouse |
Anti-Rituximab Antibodies (recommended for PK/PD)
|
Hybridoma |
|
|
|
|
|
Rituximab
|
RIB-Y36
|
Mouse |
Anti-Rituximab Antibodies (recommended for ADA assay)
|
Hybridoma |
|
|
|
|
|
Cetuximab
|
CEB-Y27
|
Mouse |
Anti-Cetuximab Antibodies (recommended for ADA assay)
|
Hybridoma |
|
|
|
|
|
Cetuximab
|
CEB-Y31
|
Mouse |
Anti-Cetuximab Antibodies (Non-Neutralizing)
|
Hybridoma |
|
|
|
|
|
Cetuximab
|
CEB-Y29
|
Mouse |
Anti-Cetuximab Antibodies (recommended for PK/PD)
|
Hybridoma |
|
|
|
|
|
Cetuximab
|
CEB-BY31
|
Mouse |
Biotinylated Anti-Cetuximab Antibodies (recommended for PK/PD)
|
Hybridoma |
|
|
|
|
|
Adalimumab
|
ADB-Y23b
|
Mouse |
Anti-Adalimumab Antibodies (recommended for PK/PD)
|
HEK293 |
|
|
|
|
|
Adalimumab
|
ADB-BY17
|
Mouse |
Biotinylated Anti-Adalimumab Antibodies (recommended for PK/PD)
|
Hybridoma |
|
|
|
|
|
Bevacizumab
|
BEB-BY13
|
Mouse |
Biotinylated Anti-Bevacizumab Antibodies (recommended for PK/PD)
|
Hybridoma |
|
|
|
|
|
Bevacizumab
|
BEB-Y10
|
Mouse |
Anti-Bevacizumab Antibodies (recommended for PK/PD)
|
Hybridoma |
|
|
|
|
|
Bevacizumab
|
BEB-Y12
|
Mouse |
Anti-Bevacizumab Antibodies (recommended for neutralizing assay)
|
Hybridoma |
|
|
|
|
|
Bevacizumab
|
BEB-Y9
|
Mouse |
Anti-Bevacizumab Antibodies (recommended for ADA assay)
|
Hybridoma |
|
|
|
|
|
Trastuzumab
|
TRB-Y1b
|
Mouse |
Anti-Trastuzumab Antibodies (recommended for PK/PD)
|
HEK293 |
|
|
|
|
|
Trastuzumab
|
TRB-Y5b
|
Mouse |
Anti-Trastuzumab Antibodies (recommended for PK/PD)
|
HEK293 |
|
|
|
|
|
Nucleocapsid protein
|
NUN-S95
|
Human |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95)
|
HEK293 |
|
|
|
|
|
Nucleocapsid protein
|
NUN-S41
|
Human |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41)
|
HEK293 |
|
|
|
|
|
Nucleocapsid protein
|
NUN-S47
|
Mouse |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS47) (Trehalose free)
|
HEK293 |
|
|
|
|
|
Nucleocapsid protein
|
NUN-S46
|
Mouse |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS46) (Trehalose free)
|
HEK293 |
|
|
|
|
|
Nucleocapsid protein
|
NUN-M223
|
Mouse |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223)
|
HEK293 |
|
|
|
|
|
Nucleocapsid protein
|
NUN-S47L8
|
Mouse |
Biotinylated Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS47)
|
HEK293 |
|
|
|
|
Check out full-length Claudin 18.2, CD20 and more.
A-Z
